Globus Medical (GMED) Stock Analysis

Globus Medical (GMED) is a publicly traded company in the HEALTHCARE sector. It trades at $78.30, carries a market capitalization of $10.83B, a price-to-earnings ratio of 18.64. This page summarizes the public market data, fundamentals, and frequently asked questions for GMED, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NYSE

Key Metrics

• Price: $78.30
• Market Cap: $10.83B
• P/E Ratio: 18.64
• EPS: $4.28
• 52-Week High: $101.40
• 52-Week Low: $51.79

Market Sentiment

Globus Medical currently has a Bullish sentiment score of 0.29.

About Globus Medical

Globus Medical, Inc. (GMED) is a prominent medical device company dedicated to enhancing healthcare solutions for patients with musculoskeletal conditions. Based in Audubon, Pennsylvania, the company excels in revolutionizing spine surgery through its proprietary technologies, which encompass a broad portfolio of spinal implants and state-of-the-art robotic-assisted surgical systems. With a strong commitment to improving patient outcomes, Globus Medical harnesses advanced engineering and inno...

GNG Research Analysis

GNG Research scores Globus Medical (GMED) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for GMED.

Frequently Asked Questions

Does GMED pay dividends?

Globus Medical (GMED) does not currently pay a regular dividend.

What is GMED's P/E ratio?

Globus Medical has a price-to-earnings (P/E) ratio of 18.64.

What is GMED's market cap?

Globus Medical (GMED) has a market capitalization of $10.83B with a current stock price of $78.30.